
More automation for patient support: Accenture’s Ella and Ethan bots
Virtual assistants delivering guidance from Accenture’s Intelligent Patient Platform
One of the broad trends in
Underlying the bots is Accenture’s Intelligent Patient Platform (IPP), which is being used by pharma companies and outsourced hub providers; to this existing platform Accenture has added Einstein AI, a software development of Salesforce.com, and Amazon’s Alexa interactivity device, which enables patients and physicians to respond to Ella or Ethan. (IPP is built on Salesforce.com’s FullForce platform and Salesforce Health Cloud.)
The proof will be in the pudding whether Ella and Ethan live up to their potential, but one way or another, AI systems are going to play a larger role in patient care. There is also a data-gathering aspect to these bots: “The platform’s newest AI capabilities allow life sciences companies to make recommendations to best support the patient’s specific condition and lifestyle by gaining deeper insights into patient behavior — in real time,” said Tony Romito, managing director, Accenture Life Sciences.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.